Wells Fargo’s Cardiovascular Systems, Inc. CSII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,995
| Closed | -$199K | – | 7793 |
|
|
2023
Q1 | $199K | Buy |
9,995
+8,404
| +528% | +$145K | ﹤0.01% | 4436 |
|
|
2022
Q4 | $21.7K | Sell |
1,591
-1,206
| -43% | -$16.8K | ﹤0.01% | 5223 |
|
|
2022
Q3 | $40K | Sell |
2,797
-639
| -19% | -$9.49K | ﹤0.01% | 5059 |
|
|
2022
Q2 | $50K | Sell |
3,436
-19,594
| -85% | -$340K | ﹤0.01% | 5020 |
|
|
2022
Q1 | $520K | Sell |
23,030
-14,566
| -39% | -$283K | ﹤0.01% | 4378 |
|
|
2021
Q4 | $707K | Sell |
37,596
-34,837
| -48% | -$930K | ﹤0.01% | 4397 |
|
|
2021
Q3 | $2.38M | Buy |
72,433
+17,027
| +31% | +$635K | ﹤0.01% | 3508 |
|
|
2021
Q2 | $2.36M | Sell |
55,406
-14,152
| -20% | -$553K | ﹤0.01% | 3542 |
|
|
2021
Q1 | $2.67M | Sell |
69,558
-65,966
| -49% | -$2.81M | ﹤0.01% | 3438 |
|
|
2020
Q4 | $5.93M | Sell |
135,524
-9,255
| -6% | -$348K | ﹤0.01% | 2572 |
|
|
2020
Q3 | $5.7M | Sell |
144,779
-833
| -0.6% | -$26.9K | ﹤0.01% | 2399 |
|
|
2020
Q2 | $4.59M | Buy |
145,612
+16,314
| +13% | +$609K | ﹤0.01% | 2534 |
|
|
2020
Q1 | $4.55M | Sell |
129,298
-20,355
| -14% | -$858K | ﹤0.01% | 2306 |
|
|
2019
Q4 | $7.27M | Buy |
149,653
+15,113
| +11% | +$688K | ﹤0.01% | 2244 |
|
|
2019
Q3 | $6.39M | Buy |
134,540
+3,972
| +3% | +$187K | ﹤0.01% | 2331 |
|
|
2019
Q2 | $5.61M | Buy |
130,568
+16,590
| +15% | +$644K | ﹤0.01% | 2475 |
|
|
2019
Q1 | $4.41M | Buy |
113,978
+56,524
| +98% | +$1.92M | ﹤0.01% | 2680 |
|
|
2018
Q4 | $1.64M | Buy |
57,454
+5,409
| +10% | +$172K | ﹤0.01% | 3440 |
|
|
2018
Q3 | $2.04M | Buy |
52,045
+3,406
| +7% | +$126K | ﹤0.01% | 3392 |
|
|
2018
Q2 | $1.57M | Sell |
48,639
-2,463
| -5% | -$67.8K | ﹤0.01% | 3646 |
|
|
2018
Q1 | $1.12M | Sell |
51,102
-3,580
| -7% | -$86.1K | ﹤0.01% | 3827 |
|
|
2017
Q4 | $1.29M | Buy |
54,682
+7,429
| +16% | +$187K | ﹤0.01% | 3737 |
|
|
2017
Q3 | $1.33M | Buy |
47,253
+3,648
| +8% | +$111K | ﹤0.01% | 3636 |
|
|
2017
Q2 | $1.41M | Sell |
43,605
-49,624
| -53% | -$1.51M | ﹤0.01% | 3475 |
|
|
2017
Q1 | $2.64M | Sell |
93,229
-4,371
| -4% | -$116K | ﹤0.01% | 2971 |
|
|
2016
Q4 | $2.36M | Buy |
97,600
+82,498
| +546% | +$2.02M | ﹤0.01% | 3028 |
|
|
2016
Q3 | $359K | Sell |
15,102
-64
| -0.4% | -$1.4K | ﹤0.01% | 4137 |
|
|
2016
Q2 | $279K | Buy |
15,166
+501
| +3% | +$7.83K | ﹤0.01% | 4224 |
|
|
2016
Q1 | $151K | Buy |
14,665
+3,880
| +36% | +$39.3K | ﹤0.01% | 4584 |
|
|
2015
Q4 | $163K | Sell |
10,785
-1,079,470
| -99% | -$16M | ﹤0.01% | 4588 |
|
|
2015
Q3 | $17.3M | Buy |
1,090,255
+13,459
| +1% | +$339K | 0.01% | 1391 |
|
|
2015
Q2 | $28.5M | Sell |
1,076,796
-6,097
| -0.6% | -$197K | 0.01% | 1131 |
|
|
2015
Q1 | $42.3M | Buy |
1,082,893
+15,965
| +1% | +$550K | 0.02% | 886 |
|
|
2014
Q4 | $32.1M | Buy |
1,066,928
+172,880
| +19% | +$4.94M | 0.01% | 1006 |
|
|
2014
Q3 | $21.1M | Buy |
894,048
+24,537
| +3% | +$698K | 0.01% | 1221 |
|
|
2014
Q2 | $27.1M | Buy |
869,511
+51,150
| +6% | +$1.47M | 0.01% | 1087 |
|
|
2014
Q1 | $26M | Buy |
818,361
+208,413
| +34% | +$6.88M | 0.01% | 1097 |
|
|
2013
Q4 | $20.9M | Buy |
609,948
+93,019
| +18% | +$2.71M | 0.01% | 1213 |
|
|
2013
Q3 | $10.4M | Buy |
516,929
+195,938
| +61% | +$4.08M | ﹤0.01% | 1630 |
|
|
2013
Q2 | $6.8M | Buy |
+320,991
| New | +$6.23M | ﹤0.01% | 1863 |
|
Other funds holding CSII
Wells Fargo's CSII Position: Q2 2023 in Review
Wells Fargo sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 9,995 shares — an estimated $199K sold.
Wells Fargo first reported a position in CSII in Q2 2013 and held it in 40 quarters. The position peaked at $42.3M in Q1 2015. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.
- Wells Fargo reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
- Wells Fargo sold 9,995 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $199K.
- Wells Fargo first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 40 quarters.
- Wells Fargo's Cardiovascular Systems, Inc. position peaked at $42.3M in Q1 2015.
- 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.
Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.